释放人工智能和融合磁共振成像靶向活检的力量：改变前列腺癌诊断。
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis.
机构信息
GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique, Sorbonne Université, Paris, France.
GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
出版信息
Eur Urol Oncol. 2023 Dec;6(6):541-542. doi: 10.1016/j.euo.2023.06.013. Epub 2023 Aug 14.
Advances in artificial intelligence (AI) and medical imaging have opened new avenues for the diagnosis and management of prostate cancer. In particular, AI technology can enhance the performance of fusion magnetic resonance imaging-targeted biopsy of the prostate, and has the potential to enhance the usability and precision of this biopsy technique, guide treatment decisions, and further advance prostate cancer care.
人工智能（AI）和医学成像技术的进步为前列腺癌的诊断和治疗开辟了新途径。特别是，人工智能技术可以提高融合磁共振成像靶向前列腺活检的性能，并且有可能提高这种活检技术的可用性和精准度，指导治疗决策，并进一步推动前列腺癌的护理。
Zotero 插件